INTERSCOPE., INC

Interscope, Inc. is a medical device manufacturer specializing in minimally invasive interventional endoscopic solutions for gastroenterology and pulmonology. The company's flagship product is the EndoRotor® System, an innovative powered endoscopic device designed for tissue resection, debridement, and removal in the gastrointestinal tract. The EndoRotor® addresses critical clinical needs including endoscopic necrosectomy, management of walled-off pancreatic necrosis (WOPN), incomplete lesion resection, post-EMR scarred lesions, Barrett's esophagus treatment, and difficult-to-reach polyp removal. The device functions as a 3-in-1 tool enabling simultaneous dissection, resection, and tissue collection. With FDA 510(k) clearance for Endoscopic Powered Resection (EPR) and FDA De Novo approval for Powered Endoscopic Debridement (PED), the EndoRotor® is distributed directly in the U.S. market. Interscope collaborates with leading academic medical centers including Duke University Medical Center, Mayo Clinic, and the Arizona Center for Digestive Health to validate clinical efficacy and procedural outcomes.